OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics
Francesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Italian Journal of Dermatology and Venereology (2022) Vol. 157, Iss. 6
Closed Access | Times Cited: 6
Francesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Italian Journal of Dermatology and Venereology (2022) Vol. 157, Iss. 6
Closed Access | Times Cited: 6
Showing 6 citing articles:
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
Maria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3545-3545
Open Access | Times Cited: 11
Maria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3545-3545
Open Access | Times Cited: 11
Gender-related Therapeutical Response to Apremilast: New Insights in a Tailored Management of Psoriasis
Emanuele Trovato, Federico Bardazzi, Vito Di Lernia, et al.
Dermatology Practical & Conceptual (2025) Vol. 15, Iss. 1, pp. 4805-4805
Open Access
Emanuele Trovato, Federico Bardazzi, Vito Di Lernia, et al.
Dermatology Practical & Conceptual (2025) Vol. 15, Iss. 1, pp. 4805-4805
Open Access
Targeted therapy for immune mediated skin diseases. What should a dermatologist know?
Edinson López, Raúl Cabrera, Cristóbal Lecaros
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 4, pp. 546-567
Open Access | Times Cited: 3
Edinson López, Raúl Cabrera, Cristóbal Lecaros
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 4, pp. 546-567
Open Access | Times Cited: 3
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study
Martina Dragotto, Eugenio Capalbo, Alessandra Cartocci, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 8
Closed Access | Times Cited: 3
Martina Dragotto, Eugenio Capalbo, Alessandra Cartocci, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 8
Closed Access | Times Cited: 3
Terapia direcionada para doenças imunomediadas da pele. O que o dermatologista deve saber?
Edinson López, Raúl Cabrera, Cristóbal Lecaros
(2024) Vol. 99, Iss. 4, pp. 546-567
Open Access
Edinson López, Raúl Cabrera, Cristóbal Lecaros
(2024) Vol. 99, Iss. 4, pp. 546-567
Open Access
Bio‐experienced psoriasis patients treated with anti‐interleukin monoclonal antibodies are less likely to achieve PASI 90, PASI 100, PASI ≤ 1 and ≤3: Results from a cohort of 305 patients
Flavia Manzo Margiotta, Alessandra Michelucci, Salvatore Panduri, et al.
JEADV Clinical Practice (2023) Vol. 3, Iss. 1, pp. 65-75
Open Access
Flavia Manzo Margiotta, Alessandra Michelucci, Salvatore Panduri, et al.
JEADV Clinical Practice (2023) Vol. 3, Iss. 1, pp. 65-75
Open Access
